Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
AAM Applauds HHS For Acknowledging Brand-Driven Cost Increases
Association Recommends Policy Solutions To Congress As Proposals To Lower Prices Unveiled
Sep 14 2021
•
By
Akriti Seth
The AAM has welcomed the HHS’s plans to lower drug prices • Source: Alamy
More from Policy & Regulation
More from Generics Bulletin